Related Experiment Video
Updated: Aug 7, 2025

Biomarkers in an Animal Model for Revealing Neural, Hematologic, and Behavioral Correlates of PTSD
Published on: October 10, 2012
Abusive Head Trauma Animal Models: Focus on Biomarkers
Rahul M Nikam1,2, Heidi H Kecskemethy1,2, Vinay V R Kandula2
1Diagnostic & Research PET/MR Center, Nemours Children's Health, Wilmington, DE 19803, USA.
Abusive head trauma (AHT) is a leading cause of death in young children. Animal models offer insights into AHT
Area of Science:
- Neuroscience
- Pediatric Traumatology
- Animal Modeling
Background:
- Abusive head trauma (AHT) is a critical cause of mortality in children under two.
- Developing accurate animal models for AHT is complex due to species-specific brain structures and injury mechanisms.
- Existing models, while varied, often lack rigorous characterization and reproducibility, limiting clinical translatability.
Purpose of the Study:
- To review clinical diagnostic challenges and biomarkers for AHT.
- To describe preclinical biomarkers of secondary brain injury in AHT.
- To discuss the utility and limitations of animal models in AHT research and drug discovery.
Main Methods:
- Review of clinical and preclinical literature on abusive head trauma.
- Analysis of biomarkers associated with AHT in human cases and animal models.
- Evaluation of the strengths and weaknesses of various animal models for AHT research.
Main Results:
- Clinical diagnosis of AHT faces significant challenges, with various biomarkers identified.
- Preclinical studies highlight key mediators of secondary brain injury, including neuroinflammation (microglia, astrocytes), oxidative stress (ROS), and excitotoxicity (NMDA receptors).
- Animal models provide valuable data on biochemical pathways but have limitations in replicating human infant brain development and long-term injury impacts.
Conclusions:
- Animal models are instrumental in understanding secondary injury mechanisms in AHT, despite inherent limitations.
- Further refinement of models is needed to improve clinical translatability for AHT diagnosis and treatment development.
- Investigating biomarkers in both clinical and preclinical settings is crucial for advancing AHT research.
More Related Videos
09:49Assessing Changes in Synaptic Plasticity Using an Awake Closed-Head Injury Model of Mild Traumatic Brain Injury
Published on: January 20, 2023
08:36Development of an Uncomplicated Mild Traumatic Brain Injury Model Modified by Weight-Drop Method and Evidenced by Magnetic Resonance Imaging
Published on: April 11, 2025